Fig. 1From: Drug repurposing against COVID-19: focus on anticancer agentsSARS-CoV-2 replication, host response and interfering drugs. The drugs able to counteract the processes underlying SARS-CoV-2 replication and consequent host response, and their sites of action are shown. PBMC = Periferal Blood Mononucleate CellsBack to article page